
News|Articles|January 10, 2005
New Product Newswire
Reliant Pharmaceutical, Liberty Corner, N.J., (908) 580-1200, has gained approval for a new lipid-lowering agent. Antara (fenofibrate) Capsules are indicated as adjunctive therapy to diet to reduce elevated LDL-C, total-C, triglycerides, and ApoB and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia (Fredrickson Types IIa and IIb).
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Expands Approval of Flibanserin for Postmenopausal Women’s Sexual Health
2
Why Trump’s Second Term is Different for the MFN Drug Pricing Policy
3
Q&A: How Complex US Drug Market Impedes MFN Pricing Policy
4
Taking Care of Every Patient in Every Pharmacy
5



























































































































